New bioanalytical services available:

CYP probe and bile acid cocktail analysis Pharmacelsus has developed new bioanalytical solutions to study drug-related effects on liver functions:

Our bioanalytical lab now offers a rapid, highly-sensitive and cost-efficient method to analyse fourteen major bile acids in a single sample, allowing the generation of a comprehensive bile acid profile in plasma or in vitro samples. In addition we have developed a reliable and swift protocol for the multi-probe analysis of CYP activities, including eight major FDA- and EMA-recommended probes. Both methods support analysis of liver functions in particular in systems with low production rates, such as in vitro microtissues.

Slogan: 

Nach oben     zurück

04.07.2018

NEBUMA ist „Innovator des Jahres“

Klassensieg bei TOP 100 / Innovationsmanagement und Innovati-onserfolge überzeugen / Ehrung durch Ranga Yogeshwar.

27.06.2018

SWG beteiligt sich an der Pxio GmbH, Saarbrücken

13.03.2018

Neue Schadstoffsoftware DataCross gestartet

Umweltminister Reinhold Jost hat am 9. Januar 2018 die Neuentwicklung der tec4U-Solutions GmbH o....